Literature DB >> 1716910

Bioavailability of ketoprofen from orally administered ketoprofen-dextran ester prodrugs in the pig.

C Larsen1, B H Jensen, H P Olesen.   

Abstract

The bioavailability of ketoprofen after oral administration of aqueous solutions of various ketoprofen-dextran ester prodrugs in pigs was assessed. Conjugates derived from dextran fractions in the molecular weight range 10,000-500,000 were employed. Compared to the administration of an oral solution of an equivalent dose of parent ketoprofen, the average absorption fractions for the different prodrugs ranged from 100 to 67%. Relatively small inter-individual variation of ketoprofen bioavailability was observed. Apparently, the molecular size of the employed dextran transport group only has a minor influence on the pharmacokinetic parameters. The ketoprofen plasma profiles for all the administered prodrugs exhibited a characteristic lag time of ketoprofen appearance in the blood (2-3 h). Quite similar results were obtained from identical experiments carried out in the pig, employing naproxen-dextran esters. Thus, the present study adds support to a more versatile application of the dextran ester prodrug approach to providing selective colon delivery of drugs possessing a carboxylic acid functional group.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716910

Source DB:  PubMed          Journal:  Acta Pharm Nord        ISSN: 1100-1801


  4 in total

Review 1.  ["Targeted delivery" in the gastrointestinal tract].

Authors:  C S Leopold
Journal:  Med Klin (Munich)       Date:  1999-02-15

2.  Synthesis and in vitro evaluation of potential sustained release prodrugs via targeting ASBT.

Authors:  Xiaowan Zheng; James E Polli
Journal:  Int J Pharm       Date:  2010-07-01       Impact factor: 5.875

3.  Multiple oral administration of a ketoprofen-dextran ester prodrug in pigs: assessment of gastrointestinal bioavailability by deconvolution.

Authors:  F Larsen; B H Jensen; H P Olesen; C Larsen
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

4.  Dextran Carrier Macromolecules for Colon-specific Delivery of 5-Aminosalicylic Acid.

Authors:  P K Shrivastava; A Shrivastava; S K Sinha; S K Shrivastava
Journal:  Indian J Pharm Sci       Date:  2013-05       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.